Author:
Veeraraghavan Balaji,Bakthavatchalam Yamuna Devi,Sahni Rani Diana
Reference4 articles.
1. Evaluation of piperacillin-tazobactam ETEST for the Detection of OXA-1 resistance Mechanism among Escherichia coli and Klebsiella pneumoniae;Manuel;J Clin Microbiol,2022
2. Performance Standards for antimicrobial susceptibility testing. Twenty-Seventh informational supplement. M100S 32nd edition,2022
3. Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study;Henderson;Clin Infect Dis,2021
4. Clinical and Laboratory Standards Institute CLSI. Development of in vitro susceptibility testing criteria and quality control parameters. Approved Standard M23-A6.2018;M23 guideline, 5th edition, United States.